Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekPharmaVoice ↗
Biotechs aimed at eye diseases, autoimmune conditions and longevity medicine have pulled in some of the larges…
The WeekFiercePharma ↗
A Brukinsa regimen has delivered a large progression-free survival benefit in what BeOne Medicines called a "n…
The WeekFierceBiotech ↗
The FDA has delayed a decision on the approval of Praxis Precision Medicine's rare epilepsy prospect by three …
The WeekBriefing
The FDA’s June 2026 update again highlights brand drugs still lacking generic challengers, aiming to spur ANDA…
The WeekPharmaceutical Technology ↗
Talawar Therapeutics will use the funds to take its AD (eczema) bispecific, TALA-125, through to Phase IIb pro…
The WeekPharmaVoice ↗
The red-hot market has plenty of room for additional therapies from big-name players and clinical-stage compan…
The WeekBioPharma Dive ↗
The acquisition by royalty management company Zymeworks follows a "strategic review" triggered by the failure …
The WeekFiercePharma ↗
As Amgen prepares to defend Tavneos' market approval in the U.S., the company has received a bad omen overseas…
The WeekFierceBiotech ↗
AstraZeneca has shared the data behind previously disclosed phase 3 rare disease wins, fleshing out the case f…
The WeekBriefing
STAT News flagged two developments: a congressional bill to revamp the 340B drug discount program and talk of …
The WeekDrug Channels ↗
Happy 250th birthday, America! Before you launch your semiquincentennial festivities, Drug Channels offers som…
The WeekSTAT News ↗
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transforma…
The WeekFiercePharma ↗
Held just after the prestigious Cannes Film Festival in southern France, the Cannes Lions Festival of Creativi…
The WeekFierceBiotech ↗
Biogen isn't wasting any time integrating its multibillion-dollar purchase of Apellis, revealing plans to part…
The WeekBriefing
STAT reports that new technical advances in embryo genome editing are again stirring public and policy debate …
The WeekBriefing
Lilly’s international head says Foundayo’s European rollout will target telehealth sales, with government pric…
The WeekSTAT News ↗
The Supreme Court's ruling on Roundup shows science and law use the same word - causation - while asking diffe…
The WeekFiercePharma ↗
The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant following a mid-Ju…
The WeekFierceBiotech ↗
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial tea…
The WeekBriefing
The European Commission has launched formal antitrust proceedings into Sanofi’s flu vaccine marketing. The cas…
The WeekBriefing
Epicrispr’s EPI-321 increased lean muscle mass in early-stage patients with facioscapulohumeral muscular dystr…
The WeekSTAT News ↗
What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the lat…
The WeekAJMC ↗
Health Equity & Access Weekly Roundup: June 26, 2026…
The WeekBioPharma Dive ↗
Replimune's application is the latest example of changing attitudes at the FDA. Elsewhere, Revolution Medicine…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.